UniProt | Protein Name |
---|---|
Q9Y5P6 |
|
GO Term | Evidence Code | PMID |
---|---|---|
protein glycosylation | ||
GDP-mannose biosynthetic process |
GO Term | Evidence Code | PMID |
---|---|---|
mannose-1-phosphate guanylyltransferase (GTP) activity | ||
GTP binding | ||
protein binding |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:1756 | facial nerve disease | |
DOID:1826 | epilepsy | |
DOID:1827 | idiopathic generalized epilepsy | |
DOID:3635 | congenital myasthenic syndrome | |
DOID:4090 | agnosia | |
DOID:422 | congenital structural myopathy | |
DOID:423 | myopathy | |
DOID:4621 | holoprosencephaly | |
DOID:5327 | retinal detachment | |
DOID:539 | ophthalmoplegia |
HPO ID | HPO Term |
---|---|
HP:0007360 | Aplasia/Hypoplasia of the cerebellum |
HP:0007361 | Abnormal pons morphology |
HP:0008443 | Neuropathic spinal arthropathy |
HP:0008947 | Infantile muscular hypotonia |
HP:0008959 | Distal upper limb muscle weakness |
HP:0008981 | Calf muscle hypertrophy |
HP:0008997 | Proximal muscle weakness in upper limbs |
HP:0009028 | Generalized weakness of limb muscles |
HP:0009046 | Difficulty running |
HP:0009053 | Distal lower limb muscle weakness |
Disease ID | Disease Name |
---|---|
ORPHA:363623 |
|
ORPHA:370968 |
|
ORPHA:370959 |
|
OMIM:615351 |
|
OMIM:615350 |
|
ORPHA:353327 |
|
ORPHA:588 |
|
OMIM:615352 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
103227639 | CHLSB10361 | ||
108526985 | RHIBE18890 | ||
104667304 | RHIRO13974 | ||
100583111 | NOMLE29513 | ||
114591493 | PODMU13848 | ||
107588415 | SINGR42925 | ||
116816499 | CHEAB22838 | ||
105311242 | PTEVA16189 | ||
115043662 | ECHNA04773 | ||
115388098 | SALFA35913 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024